HTA Evidence Synthesis Statistician (2 open roles)

Job Description Summary

We are committed to fostering a versatile, commercially focused, and inspiring talent pool. Our focus is on sharing enterprise strategies while addressing the unique needs of each country as a value-added, solution-focused partner. Join the International HEOR & PCO Team, a key player in International Value & Access, leading evidence generation to demonstrate the value of our innovative medicine portfolio.

An opportunity has arisen for an experienced Senior HTA Statistician to apply innovative statistical approaches to complex health technology assessment (HTA) challenges. This role involves leading evidence synthesis from clinical, observational, and real-world data studies to support HTA submissions in a flexible, collaborative environment.

The role entails designing and executing evidence synthesis for HTA submissions, including EU HTA JCA Dossier, and developing health economic models. The position applies methodological and analytical expertise to predict the value of Novartis assets and strategize how best to demonstrate this value to external decision-makers. Effective communication and tailoring of evidence to diverse stakeholder audiences are essential.

Key responsibilities:

1. Develop core global Indirect Treatment Comparison (ITC) plans for HTA, payer, and other access assessments, submissions, and negotiations, and lead related publications.
2. Provide strategic, methodological, and analytical support to regions and countries for local HTA submissions and strategy adaptation, coordinating data requirements across functions.
3. Establish systems to proactively capture key HTA analytical requirements across international markets, informing and optimizing internal deliverables.
4. Identify preliminary ITC needs to inform value propositions, development, pricing, and strategic decisions.
5. Share best practices and learnings across regions and teams.
6. Stay updated on innovative analytical techniques to inform pricing and market access strategies.
7. Collaborate with the Medical Affairs Biostatistics team for trial analyses and HTA challenges.
8. Act as a strategic partner with HEOR & PCO and International Value & Access teams to align evidence strategies with brand and commercial goals.
9. Mentor and coach junior team members and colleagues across functions.

Essential requirements:

The ideal candidate will have a strong background in statistics, with relevant experience in HTA and clinical research.

1. MSc/PhD in Statistics, Biostatistics, or a related field, with experience in the pharmaceutical industry or life sciences consultancy.
2. 6-8 years of relevant experience in Evidence Synthesis, Health Economics, or HTA.
3. Understanding of clinical drug development and HTA regulations and processes.
4. Experience with country-specific HTA submissions.
5. Expertise in statistical methodologies for indirect treatment comparisons (ITCs) and population-adjusted indirect comparisons (PAIC).
6. Proficiency in R and/or SAS software.
7. Strong communication, problem-solving skills, and attention to detail.
8. Ability to lead in a matrix environment and collaborate across interdisciplinary teams.

Location:

This role can be based in London, UK, Basel, Switzerland, or Dublin, Ireland.

Benefits:

Learn about our support for your personal and professional growth in the Novartis Life Handbook.

Commitment to Diversity & Inclusion:

We are dedicated to creating an inclusive, diverse work environment that reflects the communities we serve.

Accessibility and Accommodation:

We provide reasonable accommodations for individuals with medical conditions or disabilities. Contact for assistance, including the job requisition number.